Household Healthcare Sector

Ikena Oncology

Market Cap: US$54.5m

An oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance.

Biomea Fusion

Market Cap: US$54.5m

A clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases.

Cytosorbents

Market Cap: US$54.5m

Engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally.

Vivos

Market Cap: US$54.4m

A radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States.

Artrya

Market Cap: AU$84.6m

A medical technology company, engages in the development and commercialisation of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia.

Biomind Labs

Market Cap: US$54.3m

A biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions.

Beamtree Holdings

Market Cap: AU$84.0m

Provides artificial intelligence-based decision support software and data insight services to healthcare industry in Australia and internationally.

Serina Therapeutics

Market Cap: US$53.9m

A biotechnology company, develops drugs to treat neurological diseases and pain.

Actinium Pharmaceuticals

Market Cap: US$53.3m

Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

HeartBeam

Market Cap: US$53.3m

Operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting.

Odonate

Market Cap: US$53.3m

A pharmaceutical company, develops therapeutics for the treatment of cancer.

Gain Therapeutics

Market Cap: US$53.1m

A biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia.

MAIA Biotechnology

Market Cap: US$52.7m

MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer.

Cyberfuels Holding

Market Cap: US$52.5m

Operates as an energy and healthcare company in the United States.

Sernova Biotherapeutics

Market Cap: CA$72.3m

Operates as a clinical-stage biotechnology company in Canada.

Prelude Therapeutics

Market Cap: US$51.6m

A clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients.

Singular Health Group

Market Cap: AU$80.3m

A medical technology company, engages in the development and commercialization of volumetric rendering platform (VRP) and software development in Australia.

Shattuck Labs

Market Cap: US$51.3m

A biotechnology company, develops antibodies for the treatment of inflammatory and immune-mediated diseases.

Hydreight Technologies

Market Cap: CA$70.9m

Provides mobile health and wellness services primarily in the United States.

Beroni Group

Market Cap: AU$75.9m

Develops and sells smoking control products, air purifiers, water filters, cosmetics, stem-cell therapies, and health care products and supplements in Australia and internationally.

VolitionRx

Market Cap: US$50.6m

A multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and diseases associated with NETosis such as sepsis in the United States and internationally.

Ondine Biomedical

Market Cap: UK£37.7m

A life-sciences company, engages in the development and commercialization of treat infections, including those caused by drug-resistant pathogens antimicrobial therapies in Canada and internationally.

Celularity

Market Cap: US$50.3m

A clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases.

Fortress Biotech

Market Cap: US$50.2m

A biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products.

SafeSpace Global

Market Cap: US$50.1m

Through its subsidiaries, develops healthcare technology solutions to enhance safety and streamline operations in hospitals, schools, transportation hubs, and industrial sites in the United States.

Century Therapeutics

Market Cap: US$49.9m

A clinical-stage biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases.

Renovaro

Market Cap: US$49.8m

A pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cancer and HIV in the United States and the Netherlands.

Recce Pharmaceuticals

Market Cap: AU$77.3m

Recce Pharmaceuticals Ltd, discovers, develops, and commercializes synthetic anti–infectives in Australia, the United Kingdom, and the United States.

OpGen

Market Cap: US$49.1m

A precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.

Precision BioSciences

Market Cap: US$48.7m

A clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States.

Artiva Biotherapeutics

Market Cap: US$48.7m

A clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.

Radius Residential Care

Market Cap: NZ$82.6m

Provides health and aged care services for elderly and disabled people in New Zealand.

bluebird bio

Market Cap: US$48.7m

A biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States.

Positron

Market Cap: US$48.5m

A nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States.

Werewolf Therapeutics

Market Cap: US$48.5m

A biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions.

Hyperfine

Market Cap: US$48.4m

A health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products.